Increasing evidence suggests that abdominal obesity and concomitant development of inflammation are major components of insulin resistance, and elevated levels of pro-inflammatory cytokines secreted from expanded adipose tissue can negatively modulate insulin signaling pathways [38]. The gene discussed is INS; the disease is Insulin resistance.